Site icon pharmaceutical daily

Global Wearable Injectors Market to Reach $4.3 Billion in 2023, Driven by Rising Incidence of Chronic Diseases and Innovative Drug Delivery Solutions – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” report has been added to ResearchAndMarkets.com’s offering.


In a landscape marked by relentless medical innovations, the global wearable injectors market is projected to scale remarkable heights, reaching a substantial valuation of $4.3 billion by the end of 2023.

Bolstered by a steady compound annual growth rate (CAGR) of approximately 9% throughout the forecast period, this growth trajectory is fueled by the mounting prevalence of chronic ailments. Conditions such as diabetes, autoimmune disorders, cardiovascular diseases, and cancer are on the rise, prompting pharmaceutical stakeholders to harness innovative strategies to address these challenges head-on.

Current Treatment Landscape

Within the spectrum of contemporary treatment options, the spotlight falls on both oral and parenteral administration of medications. Notably, parenteral drug administration, predominantly through injections, has garnered significant traction. However, this approach is not devoid of challenges – the need for frequent dosing, the potential for dosing errors, and the risk of needlestick injuries collectively erode patient adherence and therapeutic effectiveness.

Advancements in Drug Delivery

The pharmaceutical domain stands witness to a paradigm shift, thanks to groundbreaking technological advancements. This evolution has given birth to novel drug delivery devices, exemplified by the likes of wearable injectors, autoinjectors, and pen injectors.

Among these, wearable injectors occupy a pivotal position, boasting a category that encompasses on-body injectors and patch pumps. These devices wield the power of conferring sustained therapeutic effects, optimizing patient adherence and treatment outcomes. The availability of high-capacity wearable injectors streamlines the administration process and offers a plethora of dosing alternatives. Furthermore, these devices integrate cutting-edge safety mechanisms, effectively mitigating potential risks.

Key Market Insights

Leading Manufacturers in the Wearable Injectors Market

Prominent players leaving an indelible mark on the wearable injectors market include:

Wearable Injectors Market Outlook

In a landscape where the demand for effective therapeutic solutions for chronic conditions is on the ascent, the wearable injectors market is poised for exponential growth. The pervasive adoption of wearable injectors across diverse medical domains, coupled with the continuous march of technological progress, forms the bedrock of market expansion. As the canvas of healthcare undergoes a transformative evolution, wearable injectors are primed to assume a pivotal role, driving patient care to new zeniths and ultimately shaping the contours of modern healthcare delivery.

Device Profiles

  • 3 mL Micropump (Furosemide)
  • 3M hMTS (Adalimumab)
  • D-mine Pump (Apomorphine)
  • FUROSCIX On-body Infusor (Furosemide)
  • Herceptin sc Injection (Herceptin)
  • ND0612H Belt Pump (Levodopa / Carbidopa)
  • ND0612L Belt Pump (Levodopa / Carbidopa)
  • ND0612L Next Generation Patch Pump (Levodopa / Carbidopa)

For more information about this report visit https://www.researchandmarkets.com/r/y0ga1o

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version